Algorae Pharmaceuticals Limited is a pharmaceutical development company with three drug candidates and a proprietary artificial intelligence (AI) biopharmaceutical prediction platform under development. The therapeutic pipeline comprises AI-116 for dementia, AI-168 for cardiovascular disease and NTCELL for Parkinson disease.
Find out what a historical investment in Algorae Pharmaceuticals would be worth today using our 1AI stock calculator.
Buying 1AI shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Algorae Pharmaceuticals in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in 1AI
What is the ticker symbol of Algorae Pharmaceuticals?
The ticker symbol for Algorae Pharmaceuticals is 1AI.
How much is one share of 1AI?
One share of 1AI is valued at $0.01 as of 20 November 2026.
What is the market capitalisation of Algorae Pharmaceuticals 1AI?
As of 20 November 2026 Algorae Pharmaceuticals has a market cap of $18.25M.
What is the P/E ratio of 1AI?
The Price to Earnings ratio of 1AI is -6.00.
What is the Earnings Per Share of 1AI?
The Earnings Per Share of 1AI is -$0.00.
What is the 52-week high for Algorae Pharmaceuticals stock?
The Algorae Pharmaceuticals 52-week high stock price is $0.02.
What is the 52-week low for Algorae Pharmaceuticals stock?
The Algorae Pharmaceuticals 52-week low stock price is $0.01.
Can I buy 1AI shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy 1AI shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.